|
⚲
|
| Keyboard |
| Garry Menzel | |
|---|---|
| Firm | |
| Address | c/o Black Diamond Therapeutics, Inc 139 Main Street Cambridge, MA 02142 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Black Diamond Therapeutics Inc | 021-354957 | Director | 85.0 M of 85.0 M |
||
| Black Diamond Therapeutics Inc | 021-329523 | Director | 44.2 M of 87.2 M |
||
| Black Diamond Therapeutics Inc | 021-319777 | Director | 5.0 M of 10.0 M |
||
| ASET Therapeutics Inc | 021-283424 | Director | 12.1 M of 12.1 M |
||
| Axcella Health Inc | 021-258026 | Executive Officer | 42.5 M | ||
| Pronutria Biosciences Inc | 021-234192 | Executive Officer | 44.3 M | ||
| Regulus Therapeutics Inc | 021-185938 | Executive Officer | 25.0 M of 25.0 M |
||
| Regulus Therapeutics Inc | 021-185940 | Executive Officer | 5.0 M of 5.0 M |
||
| Regulus Therapeutics Inc | 021-150536 | Executive Officer | 29.8 M of 29.8 M |
||
| Regulus Therapeutics Inc | 021-150541 | Executive Officer | 10.0 M of 10.0 M |
||
| Regulus Therapeutics Inc | 021-150538 | Executive Officer | 20.0 M of 20.0 M |
||